Simon Bradstreet explores a recent qualitative study looking at 20 years in the lives of a group of 20 people with psychosis in Ireland. The research provides evidence on the pros and cons of the adoption of recovery-based approaches from people who are uniquely placed to provide a long-term view.
[read the full story...]
Shuichi Suetani writes his debut elf blog on a new meta-review that asks: Is psychosis a multisystem disorder? This blog explores central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models.
[read the full story...]
Ian Hamilton and Suzi Gage explain why we know so little about the relationship between cannabis and severe mental illness in women.
[read the full story...]
Elwira Lubos summarises a recent review of reviews looking at the evidence for improving outcomes in first-episode psychosis.
[read the full story...]
Dan Joyce publishes his debut blog on a recent paper in the British Journal of Psychiatry that considers the feasibility and clinical utility of magnetic resonance imaging in first-episode psychosis.
[read the full story...]
Thomas Richardson writes his debut blog about a recent prospective analysis of poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis.
[read the full story...]
Jazz Croft considers a recent systematic review about traumatic experiences in first-episode psychosis, which finds that nearly 1 in 3 people with first episode psychosis met diagnostic criteria for PTSD.
[read the full story...]
Raphael Underwood on a recent systematic review of mental health-related stigma and pathways to care for people at risk of psychotic disorders or experiencing first-episode psychosis.
[read the full story...]
Marcus Munafo appraises a recent cross sectional study of tobacco smoking and its association with cognition in first episode psychosis patients.
[read the full story...]
Carmine Pariante considers the implications of a recent case-control study, which looks at the prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis.
[read the full story...]
